The high specificity of CELA3B immunostaining for pancreatic acinar carcinoma is also consistent with RNA expression data summarized in the TCGA/ICGC database (https://www.cancer.gov/tcga). This evidence concerns the gene CELA3B and familial pancreatic carcinoma.